Detailed information for compound 1998214

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 448.544 | Formula: C22H24N8OS
  • H donors: 2 H acceptors: 5 LogP: 2.43 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1csc(n1)Nc1ncc2c(n1)n(C1CCCC1)c1c2ccnc1)N1CCNCC1
  • InChi: 1S/C22H24N8OS/c31-20(29-9-7-23-8-10-29)17-13-32-22(26-17)28-21-25-11-16-15-5-6-24-12-18(15)30(19(16)27-21)14-3-1-2-4-14/h5-6,11-14,23H,1-4,7-10H2,(H,25,26,27,28)
  • InChiKey: FICIRDHVWSBGDI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cyclin-dependent kinase 6 Starlite/ChEMBL No references
Homo sapiens cyclin-dependent kinase 4 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus cyclin dependent kinase 6 Get druggable targets OG5_133618 All targets in OG5_133618
Echinococcus multilocularis cyclin dependent kinase 6 Get druggable targets OG5_133618 All targets in OG5_133618
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_133618 All targets in OG5_133618
Schistosoma japonicum ko:K02091 cyclin-dependent kinase 6, putative Get druggable targets OG5_133618 All targets in OG5_133618

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei mitogen-activated protein kinase 5 cyclin-dependent kinase 6 326 aa 314 aa 31.2 %
Trypanosoma brucei mitogen-activated protein kinase 5 cyclin-dependent kinase 4 303 aa 312 aa 29.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica P-glycoprotein-2 0.0042 0.1337 0.1337
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Plasmodium vivax aspartyl proteinase, putative 0.0014 0.0048 0.0362
Toxoplasma gondii aspartyl proteinase (eimepsin), putative 0.0014 0.0048 0.0362
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Trypanosoma cruzi sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional 0.0117 0.4835 1
Trichomonas vaginalis ABC transporter, putative 0.0042 0.1337 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Trichomonas vaginalis abcb9, putative 0.0042 0.1337 1
Chlamydia trachomatis ABC transporter ATP binding protein/permease 0.0042 0.1337 0.5
Echinococcus granulosus 5'partial|ATP binding cassette sub family B 0.0041 0.1316 0.1497
Giardia lamblia Multidrug resistance-associated protein 1 0.0013 0 0.5
Schistosoma mansoni multidrug resistance protein 0.0042 0.1337 0.1521
Schistosoma mansoni serine/threonine protein kinase 0.0203 0.8791 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Echinococcus granulosus multidrug resistance protein 1 0.0029 0.075 0.0853
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0029 0.075 0.5606
Loa Loa (eye worm) hypothetical protein 0.0014 0.0048 0.0362
Wolbachia endosymbiont of Brugia malayi ABC-type multidrug transport system, ATPase and permease component 0.0013 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0042 0.1337 1
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Brugia malayi multidrug resistance protein 3 0.0042 0.1337 1
Echinococcus granulosus cathepsin d lysosomal aspartyl protease 0.0014 0.0048 0.0055
Mycobacterium ulcerans transmembrane ABC transporter ATP-binding protein 0.0013 0 0.5
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0042 0.1337 0.1521
Echinococcus multilocularis multidrug resistance protein 1 0.0042 0.1337 0.1521
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) 0.0014 0.0048 0.0055
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0042 0.1337 0.1521
Entamoeba histolytica P-glycoprotein-2, putative 0.0042 0.1337 0.1337
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0042 0.1337 0.1521
Echinococcus granulosus multidrug resistance protein 1 0.0029 0.075 0.0853
Toxoplasma gondii ABC transporter transmembrane region domain-containing protein 0.0042 0.1337 1
Echinococcus multilocularis ATP binding cassette sub family B 0.0041 0.1316 0.1497
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0042 0.1337 1
Mycobacterium leprae PROBABLE DRUGS-TRANSPORT TRANSMEMBRANE ATP-BINDING PROTEIN ABC TRANSPORTER 0.0013 0 0.5
Loa Loa (eye worm) ATP-binding cassette sub-family B member 2 0.0042 0.1337 1
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0042 0.1337 0.1521
Brugia malayi ABC transporter family protein 0.0042 0.1337 1
Entamoeba histolytica P-glycoprotein-2 0.0042 0.1337 0.1337
Loa Loa (eye worm) hypothetical protein 0.0042 0.1337 1
Echinococcus multilocularis multidrug resistance protein 1 0.0029 0.075 0.0853
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0042 0.1337 0.1521
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Echinococcus multilocularis multidrug resistance protein 1 0.0042 0.1337 0.1521
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0042 0.1337 0.1521
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0042 0.1337 0.1521
Loa Loa (eye worm) hypothetical protein 0.0041 0.1316 0.9841
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Mycobacterium leprae PROBABLE DRUGS-TRANSPORT TRANSMEMBRANE ATP-BINDING PROTEIN ABC TRANSPORTER 0.0013 0 0.5
Giardia lamblia MRP-like ABC transporter 0.0013 0 0.5
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase 0.0014 0.0048 0.0362
Loa Loa (eye worm) aspartic protease BmAsp-2 0.0014 0.0048 0.0362
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Toxoplasma gondii aspartyl protease ASP1 0.0014 0.0048 0.0362
Mycobacterium ulcerans transmembrane ABC transporter ATP-binding protein 0.0013 0 0.5
Schistosoma mansoni multidrug resistance protein 0.0042 0.1337 0.1521
Schistosoma mansoni multidrug resistance protein 0.0042 0.1337 0.1521
Entamoeba histolytica P-glycoprotein-5 0.0042 0.1337 0.1337
Echinococcus granulosus multidrug resistance protein 1 0.0042 0.1337 0.1521
Trichomonas vaginalis ABC transporter, putative 0.0042 0.1337 1
Trichomonas vaginalis ABC transporter, putative 0.0042 0.1337 1
Plasmodium falciparum plasmepsin IV 0.0014 0.0048 0.0362
Mycobacterium ulcerans drugs-transport transmembrane ATP-binding protein ABC transporter 0.0013 0 0.5
Trichomonas vaginalis abcb9, putative 0.0042 0.1337 1
Echinococcus granulosus cyclin dependent kinase 6 0.0203 0.8791 1
Trichomonas vaginalis taga, putative 0.0042 0.1337 1
Plasmodium falciparum plasmepsin II 0.0014 0.0048 0.0362
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0042 0.1337 0.1521
Giardia lamblia ABC transporter, putative 0.0013 0 0.5
Mycobacterium tuberculosis Probable transmembrane multidrug efflux pump 0.0042 0.1337 1
Loa Loa (eye worm) multidrug resistance protein 3 0.0042 0.1337 1
Plasmodium falciparum multidrug resistance protein 1 0.0042 0.1337 1
Trichomonas vaginalis abcb9, putative 0.0042 0.1337 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0042 0.1337 1
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) 0.0014 0.0048 0.0055
Plasmodium vivax plasmepsin IV, putative 0.0014 0.0048 0.0362
Entamoeba histolytica P-glycoprotein-1 0.0042 0.1337 0.1337
Leishmania major p-glycoprotein 0.0042 0.1337 0.2765
Leishmania major phosphatidylcholine:ceramide cholinephosphotransferase 2 0.0117 0.4835 1
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0042 0.1337 1
Giardia lamblia Multidrug resistance-associated protein 1 0.0013 0 0.5
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Echinococcus multilocularis cyclin dependent kinase 6 0.0203 0.8791 1
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0042 0.1337 1
Plasmodium vivax multidrug resistance protein 1, putative 0.0042 0.1337 1
Plasmodium falciparum plasmepsin I 0.0014 0.0048 0.0362
Plasmodium falciparum plasmepsin VI 0.0014 0.0048 0.0362
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Leishmania major ATP-binding cassette protein subfamily B, member 2, putative 0.0042 0.1337 0.2765
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Trichomonas vaginalis ABC transporter, half transporter, putative 0.0042 0.1337 1
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0042 0.1337 1
Echinococcus granulosus multidrug resistance protein 1 0.0042 0.1337 0.1521
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0042 0.1337 0.1521
Wolbachia endosymbiont of Brugia malayi ABC-type protease secretion system, ATPase and permease component, AprD 0.0013 0 0.5
Trichomonas vaginalis ABC transporter, half transporter, putative 0.0042 0.1337 1
Mycobacterium ulcerans transmembrane ABC transporter ATP-binding protein 0.0013 0 0.5
Schistosoma mansoni cathepsin D (A01 family) 0.0042 0.1329 0.1512
Schistosoma mansoni smdr2 0.0042 0.1337 0.1521
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1
Entamoeba histolytica P-glyco protein 6, putative 0.0042 0.1337 0.1337
Trichomonas vaginalis ABC transporter, putative 0.0042 0.1337 1
Trypanosoma brucei sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional 0.0117 0.4835 1
Trypanosoma brucei sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional 0.0117 0.4835 1
Echinococcus granulosus multidrug resistance protein 1 0.0042 0.1337 0.1521
Mycobacterium ulcerans component linked with the assembly of cytochrome transport transmembrane ATP-binding protein ABC transporter CydD 0.0013 0 0.5
Schistosoma mansoni cathepsin D (A01 family) 0.0042 0.1329 0.1512
Trypanosoma cruzi sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional 0.0117 0.4835 1
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0042 0.1337 1
Toxoplasma gondii ATP-binding cassette transporter ABC.B1 0.0042 0.1337 1
Onchocerca volvulus 0.0042 0.1337 0.5
Entamoeba histolytica P-glycoprotein 5, putative 0.0042 0.1337 0.1337
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0042 0.1337 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2.5 nM BindingDB_Patents: In Vitro Assay. The Cdk4 and Cdk6 inhibitory activity of the compounds is measured with a kinase inhibition assay using recombinant Cdk4/CyclinD1 or Cdk6/CyclinD3 protein complexes. The protein substrate used in the assay is the retinoblastoma protein (Rb). The kinase reactions are carried out in a 96-well filter plate (MSDV N6B50, Millipore). Compounds are serially diluted in kinase buffer (20 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM DTT, 1 mg/ml BSA) and added to the reaction mixture containing 2.5 ng/ml Cdk4/CyclinD1 or Cdk6/CyclinD3, 25 µM ATP, 10 µCi/ml [33P]-ATP, 0.1 µg/ml Rb in the kinase buffer. The mixture is incubated at room temperature for 1 hour and the proteins precipitated with an equal volume of 20% TCA. The plates are washed with 10% TCA according to the manufacturer's instruction and dried at room temperature. The amount of the phosphorylated Rb is determined with a TopCount (PerkinElmer). ChEMBL. No reference
IC50 (binding) = 6.5 nM BindingDB_Patents: In Vitro Assay. The Cdk4 and Cdk6 inhibitory activity of the compounds is measured with a kinase inhibition assay using recombinant Cdk4/CyclinD1 or Cdk6/CyclinD3 protein complexes. The protein substrate used in the assay is the retinoblastoma protein (Rb). The kinase reactions are carried out in a 96-well filter plate (MSDV N6B50, Millipore). Compounds are serially diluted in kinase buffer (20 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM DTT, 1 mg/ml BSA) and added to the reaction mixture containing 2.5 ng/ml Cdk4/CyclinD1 or Cdk6/CyclinD3, 25 uM ATP, 10 uCi/ml [33P]-ATP, 0.1 ug/ml Rb in the kinase buffer. The mixture is incubated at room temperature for 1 hour and the proteins precipitated with an equal volume of 20% TCA. The plates are washed with 10% TCA according to the manufacturer's instruction and dried at room temperature. The amount of the phosphorylated Rb is determined with a TopCount (PerkinElmer). ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.